AR044507A1 - Compuestos de quinolina y quinoxalina - Google Patents

Compuestos de quinolina y quinoxalina

Info

Publication number: AR044507A1
Authority: AR; Argentina
Prior art keywords: substituted; carbon; optionally; nitrogen; optionally mono
Prior art date: 2003-03-28

Application number

ARP040101024A

Other languages

English (en)

Spanish (es)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-28

Filing date

2004-03-26

Publication date

2005-09-14

2004-03-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-09-14 Publication of AR044507A1 publication Critical patent/AR044507A1/es

Links

SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title abstract 4
XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical class N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 41
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 38
229910052757 nitrogen Inorganic materials 0.000 abstract 32
229910052799 carbon Inorganic materials 0.000 abstract 28
229920006395 saturated elastomer Polymers 0.000 abstract 23
125000004043 oxo group Chemical group O=* 0.000 abstract 22
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 18
229910052717 sulfur Inorganic materials 0.000 abstract 18
239000011593 sulfur Chemical group 0.000 abstract 18
125000005842 heteroatom Chemical group 0.000 abstract 16
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 13
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 13
229910052760 oxygen Inorganic materials 0.000 abstract 13
239000001301 oxygen Substances 0.000 abstract 13
125000005843 halogen group Chemical group 0.000 abstract 12
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 9
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 7
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 7
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 7
125000004414 alkyl thio group Chemical group 0.000 abstract 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 6
125000004093 cyano group Chemical group *C#N 0.000 abstract 6
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 6
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 4
125000000217 alkyl group Chemical group 0.000 abstract 4
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 4
125000001424 substituent group Chemical group 0.000 abstract 4
125000002619 bicyclic group Chemical group 0.000 abstract 3
235000012000 cholesterol Nutrition 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 abstract 2
102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
125000001153 fluoro group Chemical group F* 0.000 abstract 2
150000002632 lipids Chemical class 0.000 abstract 2
150000003626 triacylglycerols Chemical class 0.000 abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 abstract 1
201000001320 Atherosclerosis Diseases 0.000 abstract 1
-1 C1- alkylthio 4 Chemical group 0.000 abstract 1
208000024172 Cardiovascular disease Diseases 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
238000008214 LDL Cholesterol Methods 0.000 abstract 1
102000007330 LDL Lipoproteins Human genes 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
150000001721 carbon Chemical group 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000002883 imidazolyl group Chemical group 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 abstract 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 abstract 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ARP040101024A 2003-03-28 2004-03-26 Compuestos de quinolina y quinoxalina AR044507A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US45827403P	2003-03-28	2003-03-28

Publications (1)

Publication Number	Publication Date
AR044507A1 true AR044507A1 (es)	2005-09-14

Family

ID=33098266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP040101024A AR044507A1 (es)	2003-03-28	2004-03-26	Compuestos de quinolina y quinoxalina

Country Status (25)

Country	Link
EP (1)	EP1622872A1 (pt)
JP (1)	JP2006521344A (pt)
KR (1)	KR100729883B1 (pt)
CN (1)	CN1795177A (pt)
AR (1)	AR044507A1 (pt)
AU (1)	AU2004224082A1 (pt)
BR (1)	BRPI0408897A (pt)
CA (1)	CA2520405A1 (pt)
CL (1)	CL2004000639A1 (pt)
EA (1)	EA200501376A1 (pt)
EC (1)	ECSP056040A (pt)
GT (1)	GT200400050A (pt)
HR (1)	HRP20050859A2 (pt)
MA (1)	MA27828A1 (pt)
MX (1)	MXPA05010456A (pt)
NL (1)	NL1025839C2 (pt)
NO (1)	NO20054989L (pt)
OA (1)	OA13153A (pt)
PA (1)	PA8598901A1 (pt)
PE (1)	PE20050389A1 (pt)
TN (1)	TNSN05243A1 (pt)
TW (1)	TWI285641B (pt)
UY (1)	UY28243A1 (pt)
WO (1)	WO2004085401A1 (pt)
ZA (1)	ZA200507819B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RS20050532A (sr)	2003-01-14	2007-12-31	Arena Pharmaceuticals Inc.,	Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
EP4101846B1 (en)	2003-04-11	2023-08-02	PTC Therapeutics, Inc.	1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
KR20060056944A (ko)	2003-07-14	2006-05-25	아레나 파마슈티칼스, 인크.	대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료
US20070149567A1 (en) *	2004-09-23	2007-06-28	Pfizer Inc	Quinoline compounds
WO2006033001A1 (en) *	2004-09-23	2006-03-30	Pfizer Products Inc.	Quinoline compounds
AR051780A1 (es) *	2004-11-29	2007-02-07	Japan Tobacco Inc	Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
MY148521A (en)	2005-01-10	2013-04-30	Arena Pharm Inc	Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
BRPI0608553A2 (pt) *	2005-02-24	2010-01-12	Millennium Pharm Inc	antagonistas de receptor de pgd2 para o tratamento de doenças inflamatórias
US7888376B2 (en) *	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
PE20071025A1 (es) *	2006-01-31	2007-10-17	Mitsubishi Tanabe Pharma Corp	Compuesto amina trisustituido
US7745477B2 (en) *	2006-02-07	2010-06-29	Hoffman-La Roche Inc.	Heteroaryl and benzyl amide compounds
UY30244A1 (es)	2006-03-30	2007-11-30	Tanabe Seiyaku Co	Un proceso para preparar derivados de tetrahidroquinolina
AU2007247385B2 (en)	2006-05-10	2011-07-14	Novartis Ag	Bicyclic derivatives as CETP inhibitors
US20080305169A1 (en) *	2006-05-26	2008-12-11	Japan Tobacco Inc.	Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
JP4108729B2 (ja) *	2006-05-26	2008-06-25	日本たばこ産業株式会社	窒素含有縮合環化合物含有医薬組成物
MX2009005249A (es) *	2006-11-15	2009-05-28	Novartis Ag	Compuestos organicos.
JP4846769B2 (ja) *	2007-07-30	2011-12-28	田辺三菱製薬株式会社	医薬組成物
US8222243B2 (en)	2007-08-27	2012-07-17	Dart Neuroscience (Cayman) Ltd	Therapeutic isoxazole compounds
CA2741153A1 (en) *	2008-10-29	2010-05-06	F. Hoffmann-La Roche Ag	Novel phenyl amide or pyridyl amide derivatives and their use as gpbar1 agonists
US8420647B2 (en) *	2010-01-21	2013-04-16	Hoffmann-La Roche Inc.	4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds
CN103221410B (zh)	2010-09-22	2017-09-15	艾尼纳制药公司	Gpr119受体调节剂和对与其相关的障碍的治疗
RU2720237C2 (ru) *	2013-11-18	2020-04-28	Форма Терапеутикс, Инк.	Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
BR122019007990B1 (pt)	2013-11-18	2021-05-04	Forma Therapeutics, Inc	Composto, e, composição farmacêutica
WO2015134711A1 (en)	2014-03-06	2015-09-11	Ptc Therapeutics, Inc.	Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
CA3002540C (en)	2015-01-06	2023-11-07	Arena Pharmaceuticals, Inc.	Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja)	2015-06-22	2021-03-03	アリーナファーマシューティカルズ，インコーポレイテッド	Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
TW201729807A (zh)	2015-10-30	2017-09-01	Ｐｔｃ治療公司	用於治療癲癇的方法
CN110520124A (zh)	2017-02-16	2019-11-29	艾尼纳制药公司	用于治疗原发性胆汁性胆管炎的化合物和方法
JP7397011B2 (ja)	2018-06-06	2023-12-12	アリーナファーマシューティカルズ，インコーポレイテッド	Ｓ１ｐ１受容体に関連する状態を治療する方法
CN110452183B (zh) *	2019-09-04	2023-03-14	中国科学院上海有机化学研究所	一种手性杂环化合物的制备方法
CN111440162A (zh) *	2020-04-01	2020-07-24	邱曲真	噻唑二氢萘类衍生物及其在代谢性疾病中的应用
CN114656406B (zh) *	2022-01-25	2023-09-05	阿里生物新材料（常州）有限公司	一种2-氟代嘧啶-4-羧酸的合成方法
CN115894358B (zh) *	2022-10-25	2025-05-27	广东省农业科学院蚕业与农产品加工研究所	一种具有脂肪酶抑制活性的米糠生物碱、药物组合物及其制备方法和应用
AU2024387082A1 (en) *	2023-11-21	2026-06-04	Fmc Corporation	Substituted tetrahydroquinoline and tetrahydroquinoxaline herbicides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE351464C (de) *	1917-12-18	1922-04-07	Chemische Werke Grenzach Aktie	Verfahren zur Darstellung von Derivaten einer hydrierten 2-Phenylchinolin-4-carbonsaeure
AU717251B2 (en) *	1994-12-22	2000-03-23	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US5965572A (en) *	1996-10-28	1999-10-12	The United States Of America As Respresented By The Secretary Of The Army	Methods for treating antibiotic-resistant infections
US6103905A (en) *	1997-06-19	2000-08-15	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2717899A (en) *	1998-01-26	1999-08-09	Smithkline Beecham Plc	Quinoline derivatives as antibacterials
GT199900147A (es) *	1998-09-17	1999-09-06		1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
CO5271716A1 (es) *	1999-11-30	2003-04-30	Pfizer Prod Inc	Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida

2004
- 2004-03-15 JP JP2006506369A patent/JP2006521344A/ja active Pending
- 2004-03-15 AU AU2004224082A patent/AU2004224082A1/en not_active Abandoned
- 2004-03-15 BR BRPI0408897-2A patent/BRPI0408897A/pt not_active IP Right Cessation
- 2004-03-15 CA CA002520405A patent/CA2520405A1/en not_active Abandoned
- 2004-03-15 CN CNA2004800146455A patent/CN1795177A/zh active Pending
- 2004-03-15 KR KR1020057018383A patent/KR100729883B1/ko not_active Expired - Fee Related
- 2004-03-15 HR HR20050859A patent/HRP20050859A2/hr not_active Application Discontinuation
- 2004-03-15 OA OA1200500269A patent/OA13153A/en unknown
- 2004-03-15 EA EA200501376A patent/EA200501376A1/ru unknown
- 2004-03-15 EP EP04720668A patent/EP1622872A1/en not_active Withdrawn
- 2004-03-15 WO PCT/IB2004/000836 patent/WO2004085401A1/en not_active Ceased
- 2004-03-15 MX MXPA05010456A patent/MXPA05010456A/es unknown
- 2004-03-23 GT GT200400050A patent/GT200400050A/es unknown
- 2004-03-25 CL CL200400639A patent/CL2004000639A1/es unknown
- 2004-03-25 UY UY28243A patent/UY28243A1/es not_active Application Discontinuation
- 2004-03-26 AR ARP040101024A patent/AR044507A1/es unknown
- 2004-03-26 TW TW093108314A patent/TWI285641B/zh not_active IP Right Cessation
- 2004-03-26 NL NL1025839A patent/NL1025839C2/nl not_active IP Right Cessation
- 2004-03-26 PE PE2004000323A patent/PE20050389A1/es not_active Application Discontinuation
- 2004-03-26 PA PA20048598901A patent/PA8598901A1/es unknown
2005
- 2005-09-26 EC EC2005006040A patent/ECSP056040A/es unknown
- 2005-09-27 ZA ZA200507819A patent/ZA200507819B/xx unknown
- 2005-09-28 TN TNP2005000243A patent/TNSN05243A1/fr unknown
- 2005-09-28 MA MA28519A patent/MA27828A1/fr unknown
- 2005-10-26 NO NO20054989A patent/NO20054989L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TWI285641B (en)	2007-08-21
CA2520405A1 (en)	2004-10-07
EA200501376A1 (ru)	2006-04-28
JP2006521344A (ja)	2006-09-21
HRP20050859A2 (en)	2006-02-28
PE20050389A1 (es)	2005-05-30
KR20050115938A (ko)	2005-12-08
ZA200507819B (en)	2007-04-25
NO20054989D0 (no)	2005-10-26
UY28243A1 (es)	2004-11-08
MXPA05010456A (es)	2006-03-21
NO20054989L (no)	2005-12-16
TNSN05243A1 (fr)	2007-06-11
OA13153A (en)	2006-12-13
GT200400050A (es)	2005-03-02
WO2004085401A8 (en)	2005-12-01
BRPI0408897A (pt)	2006-04-18
EP1622872A1 (en)	2006-02-08
KR100729883B1 (ko)	2007-06-18
ECSP056040A (es)	2006-01-27
NL1025839C2 (nl)	2006-09-06
WO2004085401A1 (en)	2004-10-07
CL2004000639A1 (es)	2005-02-04
PA8598901A1 (es)	2004-11-26
CN1795177A (zh)	2006-06-28
MA27828A1 (fr)	2006-04-03
TW200508222A (en)	2005-03-01
NL1025839A1 (nl)	2004-09-30
AU2004224082A1 (en)	2004-10-07

Legal Events

Date	Code	Title	Description
2014-11-07	FB	Suspension of granting procedure

Publication	Publication Date	Title
AR030523A1 (es)	2003-08-27	Compuestos 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-amino sustituidas, su uso en la preparacion de medicamentos, composiciones farmaceuticas, y equipo que los contiene.
CO5370678A1 (es)	2004-02-27	1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas
AR087919A1 (es)	2014-04-23	Heterociclos biciclicos como inhibidores de irak4
AR067105A1 (es)	2009-09-30	Moleculas pequenas que contienen boro
AR086837A1 (es)	2014-01-29	Moduladores heterociclicos de sintesis lipidica
MX2015007883A (es)	2016-03-04	Compuestos para protección de células.
MA37712B1 (fr)	2019-03-29	Inhibiteurs macrocycliques de virus flaviviridae
NZ711064A (en)	2019-06-28	Pyridone-substituted pyrazolyl compounds as serine protease inhibitors
MX2012008049A (es)	2012-08-01	Compuestos heterociclicos triciclicos, composiciones y metodos de uso de los mismos,.
MX2008011045A (es)	2008-09-08	Compuestos y derivados de dibencilamina.
CO6160237A2 (es)	2010-05-20	Pirazinonas y pirazinoles sustituidos y composiciones que los comprenden
MX2010000658A (es)	2010-03-26	Derivados de pirimidina 934.
TW200716108A (en)	2007-05-01	Thiophene compounds for inflammation and immune-related uses
RU2009148796A (ru)	2011-07-20	Производные пиперидина/пиперазина
MX2008001395A (es)	2008-04-16	Inhibidores macrociclicos del virus de la hepatitis c.
CO5150220A1 (es)	2002-04-29	4-carboxiamino-2- metil-1,2,3,4-tetrahidroquinolinas
PE20141059A1 (es)	2014-08-30	Indazoles
AR072008A1 (es)	2010-07-28	Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
PE20142081A1 (es)	2014-12-18	Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos
PA8783601A1 (es)	2009-01-23	Derivados de piperidina/piperazina
AR036365A1 (es)	2004-09-01	1,8-naftiridin-4(1h)-onas alquin-aril sustituidas y composiciones farmaceuticas que las contienen
IL181271A0 (en)	2007-07-04	Triazolophthalazine derivatives and pharmaceutical compositions containing the same
AR074487A1 (es)	2011-01-19	Tiolactamas inhibidoras de proteinquinasas plk, composiciones farmaceuticas que las contienen y usos de las mismas para el tratamiento de trastornos proliferativos e inflamatorios, en particular cancer.
AR110443A1 (es)	2019-03-27	Inhibidores de histona metiltransferasas
AR042131A1 (es)	2005-06-08	Compuestos de piperidina fenil sustituidas y su uso como activadores de ppar